SCHEMBL1716409

SCHEMBL1716409

Cc1ccc(-c2cc(O)on2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.56
NPC1 O15118 8/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
TP53 P04637 3/20 0.49
SMN1; SMN2 Q16637 5/20 0.46
THRB P10828 1/20 0.46
KDM4E B2RXH2 1/20 0.45
RXFP1 Q9HBX9 1/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 1/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360227 0.82 PTPN1 (0.44) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL28031536 0.80 RAB9A (0.57) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL12112412 0.79 RAB9A (0.66) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL4853385 0.79 RAB9A (0.61) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL21121348 0.78 NPC1 (0.73) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL18031149 0.78 NPC1 (0.73) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL19598795 0.78 RAB9A (0.86) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL9068926 0.78 S1PR1 (0.42) RAB9ANPC1MEN1KMT2ATP53
SCHEMBL9212438 0.76 RAB9A (0.56) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3358354 0.76 RAB9A (0.56) RAB9ANPC1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2735562-B2 Estrogen receptor modulators and uses thereof SERAGON PHARMACEUTICALS INC (US) 2023-11-15 EP disclosed
EP-1884511-B1 AROMATIC ETHER COMPOUNDS,PREPARATION AND USAGE THEREOF SHENYANG RES INST CHEMICAL IND (CN) 2012-01-18 EP disclosed
EP-1884511-B1 AROMATIC ETHER COMPOUNDS,PREPARATION AND USAGE THEREOF SHENYANG RES INST CHEMICAL IND (CN) 2012-01-18 EP disclosed
US-7786045-B2 Aryl ether compounds and their preparation and use thereof SINOCHEM CORPORATION (CN) 2010-08-31 US disclosed
US-7786045-B2 Aryl ether compounds and their preparation and use thereof SINOCHEM CORPORATION (CN) 2010-08-31 US disclosed
US-7786045-B2 Aryl ether compounds and their preparation and use thereof SINOCHEM CORPORATION (CN) 2010-08-31 US disclosed
US-20080275070-A1 Aryl Ether Compounds and Their Preparation and Use Thereof SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY (CN) 2008-11-06 US disclosed
US-20080275070-A1 Aryl Ether Compounds and Their Preparation and Use Thereof SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY (CN) 2008-11-06 US disclosed
US-20080275070-A1 Aryl Ether Compounds and Their Preparation and Use Thereof SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY (CN) 2008-11-06 US disclosed
CN-101119972-A Aryl ether compound and preparation and application thereof CHINA ZHONGHUA GROUP (CN) 2008-02-06 CN disclosed
EP-1884511-A1 AROMATIC ETHER COMPOUNDS,PREPARATION AND USAGE THEREOF Shenyang Research Institute of Chemical Industry (CN) 2008-02-06 EP disclosed
EP-1884511-A1 AROMATIC ETHER COMPOUNDS,PREPARATION AND USAGE THEREOF Shenyang Research Institute of Chemical Industry (CN) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275070-A1 Aryl Ether Compounds and Their Preparation and Use Thereof DDT, TYR, AHR RAB9A 1447/4885NPC1 879/4885CASP3 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.